It's really Shep's thread--I've been in
and out of MAGN and have not follwed it
as seriously. But I feel pretty good about
being in now...hope the interest keeps up,
but not letting myself get excited yet. When
you start to read about some of the medical
conditions behind the drugs these biotechs
are trying to get out, it sort of pulls you
back out of greed mode, very sobering.
As far as the stock, fortunately, I really
have no descisions to make short term, I'm in
this one for the announcement with the fall
back plan of letting the shares cook through
Squalamine...you probably saw my yahoo post
which spelled that out. However, if traders
want to take it up before the FDA speaks, I'll
be happy to sell a third of my shares up around
3 1/2, moves before news is free money. If pex
is approved I'd have a hard time selling any shares
below about $6, and only half then. The other half
will be paid for, move them to the back, let em cook
for a long time.
I would love to know what biotechnav is saying
about MAGN lately, I think they had it out as a
hold, with a "watch for developments", but I don't
know what they have out in the latest newsletter.
If pex is approved you can be sure they'll switch
that to a buy, but the primary move will be over
by the time that happens. If if if, make no mistake,
my idea is a 50/50 chance on this with the payoff
greater than the downside risk.
It is a great honor to have stolen the 200th post
from you Shep...and I didn't really even say anything. |
